Inflammasome and pyroptosis in autoimmune liver diseases

Autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), and IgG4-related sclerosing cholangitis (IgG4-SC) are the four main forms of autoimmune liver diseases (AILDs), which are all defined by an aberrant immune system attack on the liver. Most previous s...

Full description

Bibliographic Details
Main Authors: Jixuan Wang, Zhiwen Sun, Jingri Xie, Wanli Ji, Yang Cui, Zongxiong Ai, Guoying Liang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1150879/full
_version_ 1811158355143557120
author Jixuan Wang
Zhiwen Sun
Jingri Xie
Wanli Ji
Yang Cui
Zongxiong Ai
Guoying Liang
author_facet Jixuan Wang
Zhiwen Sun
Jingri Xie
Wanli Ji
Yang Cui
Zongxiong Ai
Guoying Liang
author_sort Jixuan Wang
collection DOAJ
description Autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), and IgG4-related sclerosing cholangitis (IgG4-SC) are the four main forms of autoimmune liver diseases (AILDs), which are all defined by an aberrant immune system attack on the liver. Most previous studies have shown that apoptosis and necrosis are the two major modes of hepatocyte death in AILDs. Recent studies have reported that inflammasome-mediated pyroptosis is critical for the inflammatory response and severity of liver injury in AILDs. This review summarizes our present understanding of inflammasome activation and function, as well as the connections among inflammasomes, pyroptosis, and AILDs, thus highlighting the shared features across the four disease models and gaps in our knowledge. In addition, we summarize the correlation among NLRP3 inflammasome activation in the liver-gut axis, liver injury, and intestinal barrier disruption in PBC and PSC. We summarize the differences in microbial and metabolic characteristics between PSC and IgG4-SC, and highlight the uniqueness of IgG4-SC. We explore the different roles of NLRP3 in acute and chronic cholestatic liver injury, as well as the complex and controversial crosstalk between various types of cell death in AILDs. We also discuss the most up-to-date developments in inflammasome- and pyroptosis-targeted medicines for autoimmune liver disorders.
first_indexed 2024-04-10T05:23:12Z
format Article
id doaj.art-0de25fa0b85f4598899f80996b399cbd
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-10T05:23:12Z
publishDate 2023-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-0de25fa0b85f4598899f80996b399cbd2023-03-08T05:10:48ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-03-011410.3389/fimmu.2023.11508791150879Inflammasome and pyroptosis in autoimmune liver diseasesJixuan Wang0Zhiwen Sun1Jingri Xie2Wanli Ji3Yang Cui4Zongxiong Ai5Guoying Liang6School of First Clinical Medicine, Heilongjiang University of Chinese Medicine, Harbin, ChinaDepartment of Liver, Spleen and Stomach Diseases, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, ChinaDepartment of Liver, Spleen and Stomach Diseases, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, ChinaSchool of First Clinical Medicine, Heilongjiang University of Chinese Medicine, Harbin, ChinaSchool of First Clinical Medicine, Heilongjiang University of Chinese Medicine, Harbin, ChinaSchool of First Clinical Medicine, Heilongjiang University of Chinese Medicine, Harbin, ChinaDepartment of Liver, Spleen and Stomach Diseases, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, ChinaAutoimmune hepatitis (AIH), primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), and IgG4-related sclerosing cholangitis (IgG4-SC) are the four main forms of autoimmune liver diseases (AILDs), which are all defined by an aberrant immune system attack on the liver. Most previous studies have shown that apoptosis and necrosis are the two major modes of hepatocyte death in AILDs. Recent studies have reported that inflammasome-mediated pyroptosis is critical for the inflammatory response and severity of liver injury in AILDs. This review summarizes our present understanding of inflammasome activation and function, as well as the connections among inflammasomes, pyroptosis, and AILDs, thus highlighting the shared features across the four disease models and gaps in our knowledge. In addition, we summarize the correlation among NLRP3 inflammasome activation in the liver-gut axis, liver injury, and intestinal barrier disruption in PBC and PSC. We summarize the differences in microbial and metabolic characteristics between PSC and IgG4-SC, and highlight the uniqueness of IgG4-SC. We explore the different roles of NLRP3 in acute and chronic cholestatic liver injury, as well as the complex and controversial crosstalk between various types of cell death in AILDs. We also discuss the most up-to-date developments in inflammasome- and pyroptosis-targeted medicines for autoimmune liver disorders.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1150879/fullinflammasomespyroptosisautoimmune hepatitis (AIH)primary biliary cholangitis (PBC)primary sclerosing cholangitis (PSC)gut microbiota
spellingShingle Jixuan Wang
Zhiwen Sun
Jingri Xie
Wanli Ji
Yang Cui
Zongxiong Ai
Guoying Liang
Inflammasome and pyroptosis in autoimmune liver diseases
Frontiers in Immunology
inflammasomes
pyroptosis
autoimmune hepatitis (AIH)
primary biliary cholangitis (PBC)
primary sclerosing cholangitis (PSC)
gut microbiota
title Inflammasome and pyroptosis in autoimmune liver diseases
title_full Inflammasome and pyroptosis in autoimmune liver diseases
title_fullStr Inflammasome and pyroptosis in autoimmune liver diseases
title_full_unstemmed Inflammasome and pyroptosis in autoimmune liver diseases
title_short Inflammasome and pyroptosis in autoimmune liver diseases
title_sort inflammasome and pyroptosis in autoimmune liver diseases
topic inflammasomes
pyroptosis
autoimmune hepatitis (AIH)
primary biliary cholangitis (PBC)
primary sclerosing cholangitis (PSC)
gut microbiota
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1150879/full
work_keys_str_mv AT jixuanwang inflammasomeandpyroptosisinautoimmuneliverdiseases
AT zhiwensun inflammasomeandpyroptosisinautoimmuneliverdiseases
AT jingrixie inflammasomeandpyroptosisinautoimmuneliverdiseases
AT wanliji inflammasomeandpyroptosisinautoimmuneliverdiseases
AT yangcui inflammasomeandpyroptosisinautoimmuneliverdiseases
AT zongxiongai inflammasomeandpyroptosisinautoimmuneliverdiseases
AT guoyingliang inflammasomeandpyroptosisinautoimmuneliverdiseases